Newport Half Marathon is in the books and fundraising updates!!
September 18, 2017
BENEFITING: ALZHEIMERS DRUG DISCOVERY FOUNDATION
ORGANIZER: ALZHEIMERS DRUG DISCOVERY FOUNDATION
After the recent passing of my wife's grandmother Gloria due to Alzheimer's it made me realize how terrible and devastating this disease truly is. Having a perfectly healthy person slowly lose their being is something no one should have to go through. Seeing this firsthand and feeling the pain to the family and loved ones around her really changed something inside of me and I really feel the need to do something about it.
As some of you may or may not know I have been looking forward to this year’s NY Marathon very much, and now I am happy to say that this year I will be running it with purpose. This year I have the honor and privilege to run with the Alzheimer’s Drug Discovery Foundation to help find a cure for this terrible affliction. This year I am dedicating my run so that no one else has to go through what Gloria did, and so no more families have to feel the pain of watching their loved ones disappear while still in plain sight. I want to run this race for her and for my family and all the other families that have had to go through this in the hopes this pain will disappear from this Earth eventually.
Please assist me in raising funds for ADDF this year so we all can move towards a future without Alzheimer's.
ALZHEIMERS DRUG DISCOVERY FOUNDATION wrote -
The ADDF is proud to be an official charity partner for the 2017 TCS New York City Marathon. Donations to our team, Runners for Alzheimer's Research, directly support research into new treatments for this devastating disease. In 2016, our eighteen team members raised over $100,000, far surpassing their goal.
Though we are making great strides, Alzheimer's remains the only top 10 cause of death in the U.S. that can't be prevented, cured or even slowed. By supporting drug discovery research, our marathon team will help conquer Alzheimer's!
If you are interested in running for our team, please visit our team page.
Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the ADDF provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide. The mission of the ADDF is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.
To learn more about the ADDF, please visit our website.